Several classes of medication treat anxiety, and the right choice depends on whether you need daily long-term relief or fast-acting help during acute episodes. The most commonly prescribed options are antidepressants (SSRIs and SNRIs), which are considered first-line treatment for most anxiety disorders. Other options include buspirone, benzodiazepines, certain antihistamines, and beta-blockers, each filling a different role.
SSRIs and SNRIs: The First-Line Medications
Antidepressants in the SSRI and SNRI families are the standard starting point for generalized anxiety disorder, social anxiety disorder, and panic disorder. Despite the name “antidepressant,” these medications work just as well for anxiety. They increase the availability of chemical messengers in the brain that regulate mood and stress responses.
Common SSRIs prescribed for anxiety include sertraline (Zoloft), paroxetine (Paxil), escitalopram (Lexapro), and fluoxetine (Prozac). On the SNRI side, venlafaxine (Effexor) has FDA approval for generalized anxiety, panic disorder, and social anxiety disorder. Duloxetine (Cymbalta) is approved for generalized anxiety disorder.
The major trade-off with these medications is patience. They typically take 4 to 6 weeks before you notice a meaningful difference. They’re taken daily, not as needed, and work best as a long-term strategy. Common side effects include drowsiness, dizziness, nausea, and sexual dysfunction. The FDA requires all antidepressants to carry a warning about increased risk of suicidal thoughts in children and adolescents, particularly during the first few months of treatment or when doses change. The observed rate in clinical trials was about 4% on medication versus 2% on placebo.
Benzodiazepines: Fast but Risky
Benzodiazepines like alprazolam (Xanax), lorazepam (Ativan), clonazepam (Klonopin), and diazepam (Valium) work within 30 to 60 minutes and wear off after several hours. That speed makes them useful during panic attacks or short bursts of severe anxiety. For immediate relief, nothing else in the anxiety toolkit works as fast.
The problem is dependence. Physical dependence can develop within just several days to weeks of steady use, even at prescribed doses. The FDA now requires a boxed warning on all benzodiazepines noting that their use can lead to misuse, abuse, and addiction. Stopping abruptly or tapering too quickly can trigger withdrawal reactions, including seizures. Some people experience a protracted withdrawal syndrome lasting weeks to as long as 12 months, with symptoms like rebound anxiety, insomnia, depression, tremor, and cognitive impairment.
Because of these risks, guidelines recommend limiting benzodiazepines to the lowest effective dose for the shortest possible time. When it’s time to stop, a gradual, individualized taper is necessary. There’s no one-size-fits-all schedule. If withdrawal symptoms appear during a taper, the dose may need to be temporarily raised before continuing more slowly. Most prescribers now reserve benzodiazepines for situations where other medications haven’t worked or when you need a bridge while waiting for a daily medication to take effect.
Buspirone: A Non-Addictive Alternative
Buspirone (BuSpar) treats generalized anxiety disorder without the dependence risk of benzodiazepines. It’s taken daily and, like antidepressants, requires 4 to 6 weeks to reach full effect. It won’t help during a panic attack since it doesn’t work on demand.
Its effectiveness is modest. A review by the Canadian Agency for Drugs and Technologies in Health found that buspirone’s overall effect size was small (0.17), and there’s no strong evidence it outperforms SSRIs, SNRIs, or benzodiazepines. In one head-to-head trial, buspirone initially beat sertraline at the two- and four-week marks, but by eight weeks the difference had faded. One notable finding: people who recently used benzodiazepines tended to respond less well to buspirone, possibly because the experience of fast-acting relief makes the slower, subtler effects of buspirone less satisfying.
Where buspirone shines is its side effect profile. Compared to benzodiazepines, it causes less drowsiness, fatigue, and depression. Compared to SNRIs, it causes less dry mouth. The main complaints are nausea and dizziness. For people who can’t tolerate antidepressants or who want to avoid any risk of dependence, buspirone is a reasonable option.
Hydroxyzine: An Antihistamine That Calms Anxiety
Hydroxyzine (Vistaril, Atarax) is an antihistamine with genuine anti-anxiety effects. Double-blind clinical trials have shown it performs comparably to both benzodiazepines and buspirone for generalized anxiety disorder. It can be taken daily or used as needed for acute anxiety, where it works relatively quickly, similar to how an antihistamine for allergies kicks in.
The typical effective dose in clinical trials is 50 mg per day, usually split into two or three doses, with a common starting point of 25 mg at bedtime. Sedation is the most prominent side effect, which can be a benefit or a drawback depending on whether anxiety is disrupting your sleep. A 2010 Cochrane review acknowledged its effectiveness but stopped short of recommending it as a first-line treatment due to limited study data. Still, it fills an important niche: fast-ish relief without addiction potential.
Beta-Blockers for Physical Symptoms
Propranolol and other beta-blockers don’t treat the psychological experience of anxiety. What they do is block the body’s stress response: racing heart, trembling hands, shaky voice, sweating. They slow the heart rate and lower blood pressure by dampening the effect of adrenaline on the cardiovascular system.
This makes them popular for performance anxiety and specific situational fears, like public speaking or auditions. You take them before the event, they blunt the physical symptoms, and without those symptoms feeding back into your brain, the anxiety loop often breaks on its own. Beta-blockers aren’t FDA-approved for anxiety disorders specifically, but they’re widely prescribed off-label for this purpose. They don’t cause dependence and aren’t sedating in the way benzodiazepines or antihistamines are.
Pregabalin and Gabapentin
Pregabalin (Lyrica) calms overexcited nerve activity by binding to calcium channels in the brain. Several trials have demonstrated good efficacy for generalized anxiety disorder, and it’s approved for this use in Europe, though not in the United States. It’s typically started at 75 to 150 mg at bedtime and increased to a target range of 300 to 600 mg daily. For social anxiety disorder, the effective doses tend to be higher (450 to 600 mg), which many people find harder to tolerate.
Gabapentin (Neurontin) has a similar structure and mechanism, but its evidence base for anxiety is much thinner. For generalized anxiety, only case reports support its use. For social anxiety, randomized trials show it works better than placebo, but again at doses above 2,100 mg daily, which is a lot. Both medications are used off-label for anxiety in the U.S. and carry some risk of misuse, though less than benzodiazepines.
When First-Line Medications Don’t Work
If SSRIs or SNRIs at adequate doses for adequate time don’t provide enough relief, prescribers typically try one of several strategies: switching to a different medication in the same class, combining medications, or adding a second medication on top of the first. Adding low-dose atypical antipsychotics has shown some benefit in treatment-resistant generalized anxiety, though no medication is specifically approved for this use. A meta-analysis found that augmentation strategies produced a small but statistically significant reduction in symptom severity compared to placebo, though they didn’t meaningfully improve overall functioning or increase response rates.
Combining medication with cognitive behavioral therapy is another common approach when drugs alone fall short. In practice, many people with treatment-resistant anxiety end up on a carefully managed combination tailored through trial and adjustment over months.
How Timelines Differ Across Medications
Understanding the speed of different medications helps set realistic expectations. Benzodiazepines and some antihistamines like hydroxyzine work within 30 to 60 minutes, making them useful for acute episodes. Everything else, including SSRIs, SNRIs, buspirone, and pregabalin, requires daily use for 4 to 6 weeks before the full effect becomes apparent. Some people notice partial improvement within the first two weeks, but it’s common to feel little change initially.
This gap is why many treatment plans start with both a daily medication for long-term control and a short-term as-needed option to manage symptoms while waiting for the daily medication to build up. Once the long-term medication is working, the short-term one is typically phased out.